Servikal Spinal Korddaki MS lezyonları için T1 Ağırlıklı PSIR

Transkript

Servikal Spinal Korddaki MS lezyonları için T1 Ağırlıklı PSIR
Onkoloji Özel Sayısı
Neurol Sci 2001; 22:S98-S102.
6 Polman CH, Reingold SC, Banwell B,
Clanet M, Cohen JA, Filippi M, Fujihara K,
Havrdova E, Hutchinson M, Kappos L,
Lublin FD, Montalban X, O’Connor P,
Sandberg-Wollheim M, Thompson AJ,
Waubant E, Weinshenker B, Wolinsky JS.
Diagnostic criteria for Multiple Sclerosis:
2010 Revisions to the McDonald Criteria.
ANN NEUROL 2011; 69-292-302.
7 Zivadinov R, Bakshi R. Role of Magnetic
Resonance Imaging in the Diagnosis and
Prognosis of Multiple Sclerosis. From:
Current Clinical Neurology: Multiple
Sclerosis. Edited by: Olek MJ. Humana
Press Inc., Totowa, NJ 2005.
8 Sahraian MA, Radue E-W. MS lesions in
T2-weighted images. MRI Atlas of MS
lesions. 2008, Springer.
9 Javalkar V, Manix M, Wilson J, Nanda A.
Open ring enhancement in atypical brain
demyelination. J Clin Neurosci. 2012;
19(6):910-2. doi: 10.1016/j.
jocn.2011.06.037.
10 Miller DH, Weinshenker BG, Filippi M,
Banwell BL, Cohen JA, Freedman MS,
Galetta SL, Hutchinson M, Johnson RT,
Kappos L, Kira J, Lublin FD McFarland HF,
Montalban X, Panitch H, Richert JR,
Reingold SC, Polman CH. Differential
diagnosis of suspected multiple sclerosis:
a consensus approach. Mult Scler. 2008;
14(9): 1157-1174. doi:
10.1177/1352458508096878.
11 Yacoub HA, Al-Qudahl ZA, Lee H-J, Baisre
A, Souayah N. Tumefactive Multiple
Sclerosis presenting as Acute Ischemic
Stroke. Journal of Vascular and Interventional Neurology 2011; 4(2): 21-23.
12 Granberg T, Martola J, KristoffersenWiberg M, Aspelin P, Fredrikson S. Radiologically isolated syndrome - incidental
magnetic resonance imaging findings
suggestive of multiple sclerosis, a
systematic review. MSJ 2012; 19(3)
271-280; doi:
10.1177/1352458512451943.
13 De Stefano N, Siva A. The radiologically
isolated syndrome dilemma: just an
incidental radiological finding or
presymptomatic multiple sclerosis? MSJ
2012; 19(3) 257-258; doi:
10.1177/1352458512460418.
14 Kira J, Haller S, Kesselring J, Sahraian MA.
Differential Diagnosis of Multiple
Sclerosis. In Sahraian MA, Radue EW. MRI
Atlas of MS lesions. 2008, Springer.
15 Lee D-H, Laemmer A, Waschbisch A,
Struffert T, Maihöfner C, Schwab S, Linker
RA. Neuromyelitis optica presenting with
relapses under treatment with natalizumab: a case report. Journal of medical
Case Report 2014, 8:155. doi:
10.1186/1752-1947-8-155.
16 Marcus JF, Waubant EL. Updates on clinically isolated syndrome and diagnostic
criteria for multiple sclerosis. The Neurohospitalist 2013; 3(2) 65-80. doi:
10.1177/1941874412457183.
17 Ciccarelli O. Do cortical lesions help us
to distinguish MS from NMO? Neurology
2012; 79;630-1631. doi: 10.1212/
WNL.0b013e31826e9bbf.
18 Brinar VV, Habek M. Rare infections
mimicking MS. Clin Neurol Neurosurg.
2010; 112(7):625-8. doi: 10.1016/j.
clineuro.2010.04.011.
19 Engeholm M, Leo-Kottler B, Rempp H,
Lindig T, Lerche H, Kleffner I, Henes M,
Dihné M. Encephalopathic Susac’s
Syndrome associated with livedo
racemosa in a young woman before the
completion of family planning. BMC
Neurology 2013, 13:185.
20 Bentley P, Wang T, Malik O, Nicholas R,
Ban M, Sawcer S, Sharma P. CADASIL with
cord involvement associated with a novel
and atypical NOTCH3 mutation. J Neurol
Neurosurg Psychiatry 2011; 82:855-860.
doi: 10.1136/jnnp.2010.223297.
21 Bastianello S, Pichiecchio A, Spadaro M,
Bergamaschi R, Bramanti P, Colonnese C,
Sabatini U, Uggetti C, Luccichenti G.
Atypical multiple sclerosis: MRI findings
and differential diagnosis. Neurol Sci
2004; 25:S356-S360. doi: 10.1007/
s10072-004-0340-2
Servikal Spinal Korddaki MS lezyonları
için T1 Ağırlıklı PSIR
T1 ağırlıklı PSIR, servikal spinal
korddaki MS lezyonlarının ortaya
çıkarılmasında büyük potansiyele
sahip bulunuyor.
• 3T MAGNETOM Skyra protokolünü,
• 3T and 1.5T Phoenix görüntülerini
• Bart Schraa’nın, “Servikal Spinal
Kordda Multipl Skleroz Lezyonlarının
Görüntülenmesinde T1 Ağırlıklı Faza
Duyarlı İnversiyon Kazanımı” konulu
makalesini indirmek için:
www.siemens.com/magnetom-world
İnovasyon | Mayıs 2015 | www.siemens.com.tr/inovasyon 57

Benzer belgeler

Multipl Skleroz: İmmunsüpresif Tedaviler

Multipl Skleroz: İmmunsüpresif Tedaviler sonucunda mitoksantron alanlarda atakların sıklığı ve şiddetinde % 66 oranında azalma gözlenmiştir (p<0.001) Yine tedavi alanlarda klinik progresyon anlamlı derecede daha az gözlenmiş, MR’ da da ye...

Detaylı